Celltex’s Adult Stem Cell Therapy May Help Those Affected by Dysautonomia

Share with:

FacebookTwitterGoogle


Houston-based biotechnology company recognizes October as Dysautonomia Awareness Month  

October is internationally recognized as Dysautonomia Awareness Month and Celltex Therapeutics, a Houston-based biotechnology company, is hoping to raise awareness about the “invisible disease” that affects more than 70 million people worldwide.

Dysautonomia is an umbrella term used to describe any disease or illness caused by a malfunction or imbalance of the Autonomic Nervous System (ANS). The Autonomic Nervous System controls the automatic functions of the body that one does not consciously think about – including digestion, heart rate, respiration, organ function and blood pressure. When something goes wrong in this system, it can cause serious, sometimes life-threatening, problems.

Because there is often no cure for these diseases, the goal of therapy is to improve symptoms. Celltex Therapeutics is using its proprietary stem cell culturing and banking technology to help those living with dysautonomia find relief using autologous (one’s own) adult mesenchymal stem cells (MSCs).

With the support of her family and close friends, Texas-native Sarah Hughes, 24, received her own adult stem cells from Celltex nearly 22 years after being diagnosed with systemic juvenile idiopathic arthritis (SJIA) and dysautonomia. In the days and months since her therapy, Sarah has seen incredible results. To learn more about her “before and after” Celltex stem cell therapy story, view her video: https://vimeo.com/135608723.

“Adult MSCs have the remarkable potential of migrating to different parts of the body, recognizing sites of injury and inflammation, and they are then able to reduce inflammation and repair the damaged tissue,” Celltex Chairman and CEO David Eller says. “At Celltex, our hope is that more people like Sarah, who are affected with dysautonomia and various other diseases, can discover the healing power of their own stem cells.”

The process for obtaining a client’s MSCs begins with a small thumb-sized extraction of fat from the abdominal area. The MSCs are isolated from the fat, cultured and stored cryogenically for future use. An individual can use his or her banked stem cells for regenerative therapy through IV infusions or direct injections performed by licensed physicians at Hospital Galenia in Cancun.

Share with:

FacebookTwitterGoogle